Literature DB >> 25453299

Atherosclerotic cardiovascular disease in older adults with diabetes mellitus.

Joshua I Barzilay1, Kenneth J Mukamal2, Jorge R Kizer3.   

Abstract

Diabetes mellitus exerts a strong effect on atherosclerotic cardiovascular disease risk into older age (beyond ages 70-74 years). This effect is particularly noticeable with regard to coronary artery disease and cerebral microvascular disease. Thus, diabetes mellitus in older adults deserves the same careful medical attention as it does in middle age.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Cardiovascular disease; Diabetes; Mortality; Older age; Risk; Subclinical vascular disease

Mesh：

Year:  2014        PMID： 25453299      PMCID： PMC4254762          DOI： 10.1016/j.cger.2014.09.001

Source DB:  PubMed          Journal:  Clin Geriatr Med        ISSN： 0749-0690            Impact factor:   3.076


  27 in total

1.  Fasting and 2-hour postchallenge serum glucose measures and risk of incident cardiovascular events in the elderly: the Cardiovascular Health Study.

Authors:  Nicholas L Smith; Joshua I Barzilay; Douglas Shaffer; Peter J Savage; Susan R Heckbert; Lewis H Kuller; Richard A Kronmal; Helaine E Resnick; Bruce M Psaty
Journal:  Arch Intern Med       Date:  2002-01-28

2.  Diabetes mellitus: subclinical cardiovascular disease and risk of incident cardiovascular disease and all-cause mortality.

Authors:  L H Kuller; P Velentgas; J Barzilay; N J Beauchamp; D H O'Leary; P J Savage
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-03       Impact factor: 8.311

3.  Prevalence of clinical and isolated subclinical cardiovascular disease in older adults with glucose disorders: the Cardiovascular Health Study.

Authors:  J I Barzilay; C F Spiekerman; L H Kuller; G L Burke; V Bittner; J S Gottdiener; F L Brancati; T J Orchard; D H O'Leary; P J Savage
Journal:  Diabetes Care       Date:  2001-07       Impact factor: 19.112

4.  Diabetes-related morbidity and mortality in a national sample of U.S. elders.

Authors:  Alain G Bertoni; Julie S Krop; Gerard F Anderson; Frederick L Brancati
Journal:  Diabetes Care       Date:  2002-03       Impact factor: 19.112

5.  Incidence and risk factors of silent brain infarcts in the population-based Rotterdam Scan Study.

Authors:  Sarah E Vermeer; Tom Den Heijer; Peter J Koudstaal; Matthijs Oudkerk; Albert Hofman; Monique M B Breteler
Journal:  Stroke       Date:  2003-02       Impact factor: 7.914

6.  Prevalence of subclinical atherosclerosis and cardiovascular disease and association with risk factors in the Cardiovascular Health Study.

Authors:  L Kuller; N Borhani; C Furberg; J Gardin; T Manolio; D O'Leary; B Psaty; J Robbins
Journal:  Am J Epidemiol       Date:  1994-06-15       Impact factor: 4.897

7.  Incidence, manifestations, and predictors of brain infarcts defined by serial cranial magnetic resonance imaging in the elderly: the Cardiovascular Health Study.

Authors:  W T Longstreth; Corinne Dulberg; Teri A Manolio; Michael R Lewis; Norman J Beauchamp; Daniel O'Leary; Jeff Carr; Curt D Furberg
Journal:  Stroke       Date:  2002-10       Impact factor: 7.914

8.  Why is diabetes mellitus a stronger risk factor for fatal ischemic heart disease in women than in men? The Rancho Bernardo Study.

Authors:  E L Barrett-Connor; B A Cohn; D L Wingard; S L Edelstein
Journal:  JAMA       Date:  1991-02-06       Impact factor: 56.272

9.  Prevalence and prediction of unrecognised diabetes mellitus and impaired glucose tolerance following acute stroke.

Authors:  Christopher S Gray; Jon F Scott; Joyce M French; K G M M Alberti; Janice E O'Connell
Journal:  Age Ageing       Date:  2004-01       Impact factor: 10.668

10.  Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction.

Authors:  S M Haffner; S Lehto; T Rönnemaa; K Pyörälä; M Laakso
Journal:  N Engl J Med       Date:  1998-07-23       Impact factor: 91.245
View more
  2 in total

1.  All-cause mortality and cardiovascular events in a Spanish nonagenarian cohort according to type 2 diabetes mellitus status and established cardiovascular disease.

Authors:  M A Salinero-Fort; J Mostaza; C Lahoz; J Cárdenas-Valladolid; J I Vicente-Díez; P Gómez-Campelo; J M de Miguel-Yanes
Journal:  BMC Geriatr       Date:  2022-03-18       Impact factor: 3.921

2.  WISP1 alleviates lipid deposition in macrophages via the PPARγ/CD36 pathway in the plaque formation of atherosclerosis.

Authors:  Dian Liu; Xuyang Wang; Mingjun Zhang; Jingjing Tian; Ming Liu; Tao Jin; Jinyu Pan; Mingxiao Gao; Fengshuang An
Journal:  J Cell Mol Med       Date:  2020-08-27       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.